{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:48:00Z","timestamp":1793972880493,"version":"4.8.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32071388"],"award-info":[{"award-number":["32071388"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFA0209800"],"award-info":[{"award-number":["2018YFA0209800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1166024"],"award-info":[{"award-number":["GNT1166024"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1194825"],"award-info":[{"award-number":["GNT1194825"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.biomaterials.2022.121760","type":"journal-article","created":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T05:31:26Z","timestamp":1661664686000},"page":"121760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition"],"prefix":"10.1016","volume":"289","author":[{"given":"Muhammad","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-4401","authenticated-orcid":false,"given":"Wen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5960-0279","authenticated-orcid":false,"given":"Pir","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Chaston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7403-0040","authenticated-orcid":false,"given":"Fawad Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5331-8659","authenticated-orcid":false,"given":"David B.","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2022.121760_bib1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.amjmed.2017.12.039","article-title":"Brain tumors","volume":"131","author":"McFaline-Figueroa","year":"2018","journal-title":"Am. J. Med."},{"key":"10.1016\/j.biomaterials.2022.121760_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.critrevonc.2004.10.004","article-title":"Temozolomide in the treatment of solid tumours: current results and rationale for dosing\/scheduling","volume":"53","author":"Payne","year":"2005","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.biomaterials.2022.121760_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2015.05.005","article-title":"Glioblastoma multiforme: pathogenesis and treatment","volume":"152","author":"Alifieris","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biomaterials.2022.121760_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2015.03.015","article-title":"Mechanisms regulating glioma invasion","volume":"362","author":"Paw","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2022.121760_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biomaterials.2022.121760_bib6","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3171\/2014.12.FOCUS14758","article-title":"Therapeutic strategies to improve drug delivery across the blood-brain barrier","volume":"38","author":"Azad","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.biomaterials.2022.121760_bib7","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.3171\/2015.1.FOCUS14767","article-title":"Novel delivery methods bypassing the blood-brain and blood-tumor barriers","volume":"38","author":"Hendricks","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.biomaterials.2022.121760_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/pr.57.4.2","article-title":"The evolution of iron chelators for the treatment of iron overload disease and cancer","volume":"57","author":"Kalinowski","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biomaterials.2022.121760_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrn3453","article-title":"Iron metabolism in the CNS: implications for neurodegenerative diseases","volume":"14","author":"Rouault","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.biomaterials.2022.121760_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ctrv.2008.07.004","article-title":"Elevated copper and oxidative stress in cancer cells as a target for cancer treatment","volume":"35","author":"Gupte","year":"2009","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.biomaterials.2022.121760_bib11","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1182\/blood-2004-03-0868","article-title":"Novel di-2-pyridyl\u2013derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment","volume":"104","author":"Yuan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.biomaterials.2022.121760_bib12","doi-asserted-by":"crossref","first-page":"14901","DOI":"10.1073\/pnas.0604979103","article-title":"A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics","volume":"103","author":"Whitnall","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biomaterials.2022.121760_bib13","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.jinorgbio.2010.07.012","article-title":"The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR study","volume":"104","author":"Jansson","year":"2010","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.biomaterials.2022.121760_bib14","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1158\/0008-5472.CAN-11-1218","article-title":"Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes","volume":"71","author":"Lovejoy","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121760_bib15","doi-asserted-by":"crossref","first-page":"9588","DOI":"10.1074\/jbc.M114.631283","article-title":"Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp)","volume":"290","author":"Jansson","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biomaterials.2022.121760_bib16","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1039\/b705989b","article-title":"Cu\u2013ATSM: a radiopharmaceutical for the PET imaging of hypoxia","author":"V\u0101vere","year":"2007","journal-title":"Dalton Trans."},{"key":"10.1016\/j.biomaterials.2022.121760_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nucmedbio.2009.11.004","article-title":"Some thoughts on the mechanism of cellular trapping of Cu(II)-ATSM","volume":"37","author":"Dearling","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.biomaterials.2022.121760_bib18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1039\/B512656H","article-title":"Probing the mechanism of hypoxia selectivity of copper bis(thiosemicarbazonato) complexes: DFT calculation of redox potentials and absolute acidities in solution","author":"Holland","year":"2006","journal-title":"Dalton Trans."},{"key":"10.1016\/j.biomaterials.2022.121760_bib19","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1021\/jm0104217","article-title":"Studies on the mechanism of hypoxic selectivity in copper bis(thiosemicarbazone) radiopharmaceuticals","volume":"45","author":"Maurer","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2022.121760_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/BF02988502","article-title":"Retention mechanism of hypoxia selective nuclear imaging\/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells","volume":"15","author":"Obata","year":"2001","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.biomaterials.2022.121760_bib21","doi-asserted-by":"crossref","first-page":"8021","DOI":"10.1523\/JNEUROSCI.4196-13.2014","article-title":"Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis","volume":"34","author":"Roberts","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.biomaterials.2022.121760_bib22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3109\/21678421.2013.824000","article-title":"Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis","volume":"14","author":"McAllum","year":"2013","journal-title":"Amyotroph. Lateral Scler. Front. Degener."},{"key":"10.1016\/j.biomaterials.2022.121760_bib23","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/adfm.201500061","article-title":"Remotely controlled red blood cell carriers for cancer targeting and near-infrared light-triggered drug release in combined photothermal-chemotherapy","volume":"25","author":"Sun","year":"2015","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2022.121760_bib24","doi-asserted-by":"crossref","first-page":"6225","DOI":"10.1002\/smll.201502388","article-title":"Red blood cell membrane as a biomimetic nanocoating for prolonged circulation time and reduced accelerated blood clearance","volume":"11","author":"Rao","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.biomaterials.2022.121760_bib25","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/adhm.201200138","article-title":"Erythrocyte-inspired delivery systems","volume":"1","author":"Hu","year":"2012","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.biomaterials.2022.121760_bib26","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","article-title":"Role of CD47 as a marker of self on red blood cells","volume":"288","author":"Oldenborg","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2022.121760_bib27","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1021\/acsnano.2c00893","article-title":"Cell membrane-camouflaged nanocarriers with biomimetic deformability of erythrocytes for ultralong circulation and enhanced cancer therapy","volume":"16","author":"Miao","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2022.121760_bib28","doi-asserted-by":"crossref","first-page":"8884","DOI":"10.1039\/c3nr03064d","article-title":"Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles","volume":"5","author":"Fang","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.biomaterials.2022.121760_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201803717","article-title":"Effective and targeted human orthotopic glioblastoma xenograft therapy via a multifunctional biomimetic nanomedicine","volume":"30","author":"Zou","year":"2018","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2022.121760_bib30","article-title":"Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy","author":"Liu","year":"2022","journal-title":"Explorations"},{"key":"10.1016\/j.biomaterials.2022.121760_bib31","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1021\/acs.nanolett.9b04683","article-title":"Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy","volume":"20","author":"Liu","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2022.121760_bib32","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1021\/nn5003375","article-title":"Overcoming the blood-brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist","volume":"8","author":"Gao","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2022.121760_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1039\/B612142J","article-title":"Bifunctional chelators for copper radiopharmaceuticals: the synthesis of [Cu(ATSM)\u2013amino acid] and [Cu(ATSM)\u2013octreotide] conjugates","author":"Cowley","year":"2007","journal-title":"Dalton Trans."},{"key":"10.1016\/j.biomaterials.2022.121760_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biomaterials.2022.121760_bib35","doi-asserted-by":"crossref","first-page":"6293","DOI":"10.1021\/acsnano.2c00320","article-title":"Brain-targeted codelivery of Bcl-2\/Bcl-xl and Mcl-1 inhibitors by biomimetic nanoparticles for orthotopic glioblastoma therapy","volume":"16","author":"He","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2022.121760_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/EXP.20210149","article-title":"Mitochondria-specific nanocatalysts for chemotherapy-augmented sequential chemoreactive tumor therapy","volume":"1","author":"Huang","year":"2021","journal-title":"Explorations"},{"key":"10.1016\/j.biomaterials.2022.121760_bib37","doi-asserted-by":"crossref","first-page":"9413","DOI":"10.1039\/D1TB01330K","article-title":"Glutathione-triggered nanoplatform for chemodynamic\/metal-ion therapy","volume":"9","author":"Liu","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.biomaterials.2022.121760_bib38","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0006-2952(03)00083-2","article-title":"Evaluation of the probes 2',7'-dichlorofluorescin diacetate, luminol, and lucigenin as indicators of reactive species formation","volume":"65","author":"Myhre","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biomaterials.2022.121760_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0014-5793(01)03228-8","article-title":"A study on permeability transition pore opening and cytochrome c release from mitochondria, induced by caspase-3 in vitro","volume":"510","author":"Xia","year":"2002","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biomaterials.2022.121760_bib40","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2022.121760_bib41","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/ntno.38954","article-title":"Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas","volume":"3","author":"Liu","year":"2019","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.biomaterials.2022.121760_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903277","article-title":"ROS-responsive polymeric siRNA nanomedicine stabilized by triple interactions for the robust glioblastoma combinational RNAi therapy","volume":"31","author":"Zheng","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2022.121760_bib43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cmpb.2010.01.007","article-title":"PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel, Comput","volume":"99","author":"Zhang","year":"2010","journal-title":"Methods Programs Biomed"},{"key":"10.1016\/j.biomaterials.2022.121760_bib44","doi-asserted-by":"crossref","first-page":"42411","DOI":"10.18632\/oncotarget.6389","article-title":"Novel and potent anti-tumor and anti-metastatic di-2-pyridylketone thiosemicarbazones demonstrate marked differences in pharmacology between the first and second generation lead agents","volume":"6","author":"Sestak","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.biomaterials.2022.121760_bib45","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1021\/nn5003375","article-title":"Overcoming the blood\u2013brain barrier for delivering drugs into the brain by using adenosine receptor nanoagonist","volume":"8","author":"Gao","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2022.121760_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF03165001","article-title":"Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging","volume":"9","author":"Fujibayashi","year":"1995","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.biomaterials.2022.121760_bib47","first-page":"989","article-title":"Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone)","volume":"47","author":"Yuan","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biomaterials.2022.121760_bib48","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1158\/0008-5472.CAN-04-3900","article-title":"Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat","volume":"65","author":"Schroeder","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121760_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2018.09.029","article-title":"Peptide-decorated polymeric nanomedicines for precision cancer therapy","volume":"290","author":"Sun","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2022.121760_bib50","doi-asserted-by":"crossref","first-page":"7230","DOI":"10.1021\/jm300768u","article-title":"Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo","volume":"55","author":"Lovejoy","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biomaterials.2022.121760_bib51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00775-012-0949-1","article-title":"Bis(thiosemicarbazone) copper complexes: mechanism of intracellular accumulation","volume":"18","author":"Lambert","year":"2013","journal-title":"J. Biol. Inorg. Chem."},{"key":"10.1016\/j.biomaterials.2022.121760_bib52","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/cas.14367","article-title":"SPH3643: a novel cyclin-dependent kinase 4\/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeability","volume":"111","author":"Liao","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biomaterials.2022.121760_bib53","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/1061186X.2019.1567738","article-title":"Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma","volume":"27","author":"Ganipineni","year":"2019","journal-title":"J. Drug Target."},{"key":"10.1016\/j.biomaterials.2022.121760_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.nano.2014.09.005","article-title":"A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme","volume":"11","author":"Kim","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2022.121760_bib55","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.2147\/IJN.S243878","article-title":"Combined delivery of temozolomide and siPLK1 using targeted nanoparticles to enhance temozolomide sensitivity in glioma","volume":"15","author":"Shi","year":"2020","journal-title":"Int. J. Nanomed."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:11:13Z","timestamp":1758906673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222004008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":55,"alternative-id":["S0142961222004008"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121760","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"121760"}}